- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: recurrent vulvar cancer
Total 90207 results
-
Institute of Oncology LjubljanaRecruiting
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingCervical Cancer | Ovarian Cancer | Vulvar Cancer | Endometrial Cancer | Gynecological MalignanciesGermany
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
The Netherlands Cancer InstituteRecruitingSquamous Cell Carcinoma of the Vulva | Locally Advanced Vulvar CarcinomaNetherlands
-
National Cancer Institute (NCI)RecruitingNasopharyngeal Carcinoma | Stage IV Nasopharyngeal Carcinoma AJCC v8United States
-
Vanderbilt-Ingram Cancer CenterAmerican Cancer Society, Inc.RecruitingHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell CarcinomaUnited States
-
GT Medical Technologies, Inc.Not yet recruiting
-
BGI, ChinaWuhan Union Hospital, ChinaRecruiting
-
Heinrich-Heine University, DuesseldorfNot yet recruitingSurgery | PDAC | Pancreatoduodenectomy | Margin, Resection | Local Recurrent TumorGermany
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSarcoma | Soft Tissue Sarcoma | Sarcoma,Soft Tissue | Dedifferentiated Liposarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Unresectable Dedifferentiated LiposarcomaUnited States
-
M.D. Anderson Cancer CenterGilead SciencesRecruitingSalivary Gland Cancers | GlandUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingRecurrent Colorectal Carcinoma | Advanced Colorectal CarcinomaChina
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; InSightecNot yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingHead and Neck Cancer | Lung Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Non-small Cell Lung Cancer | Sinonasal Cancer | Head and Neck CarcnimonaUnited States
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaboratorsRecruitingNasopharyngeal Carcinoma | De-escaltion TherapyChina
-
UroGen Pharma Ltd.RecruitingCarcinoma, Transitional Cell | Urothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent | Transitional Cell Carcinoma of Renal PelvisUnited States
-
The Affiliated Hospital of Qingdao UniversityRecruiting
-
Adam KittaiRecruitingRecurrent Transformed Non-Hodgkin Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recurrent Transformed... and other conditionsUnited States
-
Casey CosgroveRecruitingRecurrent Endometrial Serous AdenocarcinomaUnited States
-
Peking UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.; Beijing Biostar Pharmaceuticals...Recruiting
-
Fudan UniversityRecruitingCervical Cancer | Chemoradiotherapy | Immune Checkpoint InhibitorChina
-
National Cancer Institute (NCI)RecruitingRecurrent WHO Grade 2 Glioma | Recurrent Glioblastoma, IDH-Wildtype | Recurrent WHO Grade 3 GliomaUnited States
-
Centre Leon BerardGlaxoSmithKlineRecruitingRecurrent Cancer | Second Cancer | Primary CancerFrance
-
University of OklahomaRecruitingHead and Neck CancerUnited States
-
Sapience TherapeuticsRecruitingHepatocellular Carcinoma | Pancreatic Cancer | Ovarian Cancer | Cholangiocarcinoma | Triple Negative Breast Cancer | Metastatic Melanoma | Colon Cancer | Synovial Sarcoma | Breast Cancer Metastatic | Metastatic Colon Cancer | Melanoma Stage IV | Melanoma Recurrent | TNBC - Triple-Negative Breast Cancer | NSCLC, Metastatic and other conditionsUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Yale UniversityGilead SciencesRecruitingA Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical CancerCervical CancerUnited States
-
Shuhong YiRecruitingRecurrent Liver Cancer After Liver TransplantationChina
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
Shanghai Proton and Heavy Ion CenterRecruiting
-
PureTechRecruiting
-
National Cancer Institute (NCI)RecruitingRecurrent Langerhans Cell Histiocytosis | Refractory Langerhans Cell HistiocytosisUnited States, Canada
-
Washington University School of MedicineNational Cancer Institute (NCI); Aravive, Inc.Not yet recruitingRecurrent High Grade Uterine CancerUnited States
-
University of AlbertaRecruiting
-
Women's Hospital School Of Medicine Zhejiang UniversityAkesoNot yet recruitingCervical Cancer | Uterine Cervical Neoplasms | Cancer of Cervix | Uterine Cervical Cancer | Cervical Neoplasms | Cancer of the Uterine Cervix
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Debiopharm International SARecruitingSmall Cell Lung Cancer RecurrentUnited States, Spain
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Royal Marsden NHS Foundation TrustRecruiting
-
Xin CaiNot yet recruitingRectal Cancer | RecurrentChina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingSolid Tumor | Gynecological Malignant TumorChina
-
NX Development CorpRecruitingOvarian CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States